Enhanced immunization after intranasal coadministration of Escherichia coli heat-labile enterotoxin B subunit and human papillomavirus 16-L1 DNA vaccine

Human papillomavirus (HPV), mainly types 16 and 18, are the most important initiating agents of cervical cancer. Prevention of high-risk HPV infections is a potentially effective approach to control HPV associated cervical cancer.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chinese medical journal 2006-03, Vol.119 (5), p.408-411
Hauptverfasser: Wang, Jing, Zhao, Chang-an, Wang, Kai, Zheng, Jin, Wang, Yi-li, Si, Lü-sheng
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 411
container_issue 5
container_start_page 408
container_title Chinese medical journal
container_volume 119
creator Wang, Jing
Zhao, Chang-an
Wang, Kai
Zheng, Jin
Wang, Yi-li
Si, Lü-sheng
description Human papillomavirus (HPV), mainly types 16 and 18, are the most important initiating agents of cervical cancer. Prevention of high-risk HPV infections is a potentially effective approach to control HPV associated cervical cancer.
doi_str_mv 10.1097/00029330-200603010-00010
format Article
fullrecord <record><control><sourceid>wanfang_jour_proqu</sourceid><recordid>TN_cdi_wanfang_journals_zhcmj200605010</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>21452945</cqvip_id><wanfj_id>zhcmj200605010</wanfj_id><sourcerecordid>zhcmj200605010</sourcerecordid><originalsourceid>FETCH-LOGICAL-c421t-b06455f3fbe28922295b0d89a8d870e6e81bdf1d38b229d36533742584b037b83</originalsourceid><addsrcrecordid>eNpFkcty1DAQRb2AIiHwC5SKBTuDHpZsL0MYHlVTsIG1qvWKNcjSRLITyJfwuWgmA1mpqvv07da9TYMIfkvw2L_DGNORMdxSjAVmmOC2lgh-0pxjJkQrxnE8a56Xsqsg57141pwRwTvKB37e_NnECaK2Bvl5XqO_h8WniMAtNiMflwwRCgSkE5jZR19q5UgkhzZFTzZ7PXmo_eDRZGFpAygfLLKxKqQl_fIRvUdlVVV8QRANmtYZItrD3oeQZrj1eS2IiHZL0Ievl-gWtPbRvmieOgjFvjy9F82Pj5vvV5_b7bdPX64ut63uKFlahUXHuWNOWTqMlNKRK2yGEQYz9NgKOxBlHDFsULVnmOCM9Ye_dwqzXg3sonnzoHsH0UG8lru05lg3yvtJz7ujqbza-Qjuc7pZbVnk7Iu2IUC0aS1S9D0Xgh8UhwdQ51RKtk7us58h_5YEy0Nk8l9k8n9k8hhZHX112rGq2ZrHwVNeFXh90p5SvL7x9V4F-qerjktKOk7HjrO_T0ugBw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67756658</pqid></control><display><type>article</type><title>Enhanced immunization after intranasal coadministration of Escherichia coli heat-labile enterotoxin B subunit and human papillomavirus 16-L1 DNA vaccine</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Wang, Jing ; Zhao, Chang-an ; Wang, Kai ; Zheng, Jin ; Wang, Yi-li ; Si, Lü-sheng</creator><creatorcontrib>Wang, Jing ; Zhao, Chang-an ; Wang, Kai ; Zheng, Jin ; Wang, Yi-li ; Si, Lü-sheng</creatorcontrib><description>Human papillomavirus (HPV), mainly types 16 and 18, are the most important initiating agents of cervical cancer. Prevention of high-risk HPV infections is a potentially effective approach to control HPV associated cervical cancer.</description><identifier>ISSN: 0366-6999</identifier><identifier>DOI: 10.1097/00029330-200603010-00010</identifier><identifier>PMID: 16542585</identifier><language>eng</language><publisher>China: Key Laboratory of Biomedical Information Engineering of Education Ministry, Institute for Cancer Research, School of Life Science &amp; Technology, Xi'an Jiaotong University, Xi'an 710061,China</publisher><subject><![CDATA[Adjuvants, Immunologic - administration & dosage ; Administration, Intranasal ; Animals ; Antibodies, Viral - blood ; Bacterial Toxins - administration & dosage ; Capsid Proteins ; Enterotoxins - administration & dosage ; Escherichia coli Proteins - administration & dosage ; Female ; Hemagglutination Inhibition Tests ; Human papillomavirus 16 - immunology ; Immunization ; Interferon-gamma - biosynthesis ; Lymphocyte Activation ; Mice ; Mice, Inbred C57BL ; Oncogene Proteins, Viral - genetics ; Oncogene Proteins, Viral - immunology ; Papillomavirus Vaccines ; Vaccines, DNA - administration & dosage ; Vaccines, DNA - immunology ; Viral Vaccines - administration & dosage ; Viral Vaccines - immunology ; Virion - immunology ; 乳头状瘤病毒 ; 免疫机制 ; 埃希氏菌属 ; 疫苗 ; 鼻内管理]]></subject><ispartof>Chinese medical journal, 2006-03, Vol.119 (5), p.408-411</ispartof><rights>Copyright © Wanfang Data Co. Ltd. All Rights Reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c421t-b06455f3fbe28922295b0d89a8d870e6e81bdf1d38b229d36533742584b037b83</citedby><cites>FETCH-LOGICAL-c421t-b06455f3fbe28922295b0d89a8d870e6e81bdf1d38b229d36533742584b037b83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/85656X/85656X.jpg</thumbnail><link.rule.ids>314,776,780,860,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16542585$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Jing</creatorcontrib><creatorcontrib>Zhao, Chang-an</creatorcontrib><creatorcontrib>Wang, Kai</creatorcontrib><creatorcontrib>Zheng, Jin</creatorcontrib><creatorcontrib>Wang, Yi-li</creatorcontrib><creatorcontrib>Si, Lü-sheng</creatorcontrib><title>Enhanced immunization after intranasal coadministration of Escherichia coli heat-labile enterotoxin B subunit and human papillomavirus 16-L1 DNA vaccine</title><title>Chinese medical journal</title><addtitle>Chinese Medical Journal</addtitle><description>Human papillomavirus (HPV), mainly types 16 and 18, are the most important initiating agents of cervical cancer. Prevention of high-risk HPV infections is a potentially effective approach to control HPV associated cervical cancer.</description><subject>Adjuvants, Immunologic - administration &amp; dosage</subject><subject>Administration, Intranasal</subject><subject>Animals</subject><subject>Antibodies, Viral - blood</subject><subject>Bacterial Toxins - administration &amp; dosage</subject><subject>Capsid Proteins</subject><subject>Enterotoxins - administration &amp; dosage</subject><subject>Escherichia coli Proteins - administration &amp; dosage</subject><subject>Female</subject><subject>Hemagglutination Inhibition Tests</subject><subject>Human papillomavirus 16 - immunology</subject><subject>Immunization</subject><subject>Interferon-gamma - biosynthesis</subject><subject>Lymphocyte Activation</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Oncogene Proteins, Viral - genetics</subject><subject>Oncogene Proteins, Viral - immunology</subject><subject>Papillomavirus Vaccines</subject><subject>Vaccines, DNA - administration &amp; dosage</subject><subject>Vaccines, DNA - immunology</subject><subject>Viral Vaccines - administration &amp; dosage</subject><subject>Viral Vaccines - immunology</subject><subject>Virion - immunology</subject><subject>乳头状瘤病毒</subject><subject>免疫机制</subject><subject>埃希氏菌属</subject><subject>疫苗</subject><subject>鼻内管理</subject><issn>0366-6999</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkcty1DAQRb2AIiHwC5SKBTuDHpZsL0MYHlVTsIG1qvWKNcjSRLITyJfwuWgmA1mpqvv07da9TYMIfkvw2L_DGNORMdxSjAVmmOC2lgh-0pxjJkQrxnE8a56Xsqsg57141pwRwTvKB37e_NnECaK2Bvl5XqO_h8WniMAtNiMflwwRCgSkE5jZR19q5UgkhzZFTzZ7PXmo_eDRZGFpAygfLLKxKqQl_fIRvUdlVVV8QRANmtYZItrD3oeQZrj1eS2IiHZL0Ievl-gWtPbRvmieOgjFvjy9F82Pj5vvV5_b7bdPX64ut63uKFlahUXHuWNOWTqMlNKRK2yGEQYz9NgKOxBlHDFsULVnmOCM9Ye_dwqzXg3sonnzoHsH0UG8lru05lg3yvtJz7ujqbza-Qjuc7pZbVnk7Iu2IUC0aS1S9D0Xgh8UhwdQ51RKtk7us58h_5YEy0Nk8l9k8n9k8hhZHX112rGq2ZrHwVNeFXh90p5SvL7x9V4F-qerjktKOk7HjrO_T0ugBw</recordid><startdate>20060305</startdate><enddate>20060305</enddate><creator>Wang, Jing</creator><creator>Zhao, Chang-an</creator><creator>Wang, Kai</creator><creator>Zheng, Jin</creator><creator>Wang, Yi-li</creator><creator>Si, Lü-sheng</creator><general>Key Laboratory of Biomedical Information Engineering of Education Ministry, Institute for Cancer Research, School of Life Science &amp; Technology, Xi'an Jiaotong University, Xi'an 710061,China</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>2B.</scope><scope>4A8</scope><scope>92I</scope><scope>93N</scope><scope>PSX</scope><scope>TCJ</scope></search><sort><creationdate>20060305</creationdate><title>Enhanced immunization after intranasal coadministration of Escherichia coli heat-labile enterotoxin B subunit and human papillomavirus 16-L1 DNA vaccine</title><author>Wang, Jing ; Zhao, Chang-an ; Wang, Kai ; Zheng, Jin ; Wang, Yi-li ; Si, Lü-sheng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c421t-b06455f3fbe28922295b0d89a8d870e6e81bdf1d38b229d36533742584b037b83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adjuvants, Immunologic - administration &amp; dosage</topic><topic>Administration, Intranasal</topic><topic>Animals</topic><topic>Antibodies, Viral - blood</topic><topic>Bacterial Toxins - administration &amp; dosage</topic><topic>Capsid Proteins</topic><topic>Enterotoxins - administration &amp; dosage</topic><topic>Escherichia coli Proteins - administration &amp; dosage</topic><topic>Female</topic><topic>Hemagglutination Inhibition Tests</topic><topic>Human papillomavirus 16 - immunology</topic><topic>Immunization</topic><topic>Interferon-gamma - biosynthesis</topic><topic>Lymphocyte Activation</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Oncogene Proteins, Viral - genetics</topic><topic>Oncogene Proteins, Viral - immunology</topic><topic>Papillomavirus Vaccines</topic><topic>Vaccines, DNA - administration &amp; dosage</topic><topic>Vaccines, DNA - immunology</topic><topic>Viral Vaccines - administration &amp; dosage</topic><topic>Viral Vaccines - immunology</topic><topic>Virion - immunology</topic><topic>乳头状瘤病毒</topic><topic>免疫机制</topic><topic>埃希氏菌属</topic><topic>疫苗</topic><topic>鼻内管理</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Jing</creatorcontrib><creatorcontrib>Zhao, Chang-an</creatorcontrib><creatorcontrib>Wang, Kai</creatorcontrib><creatorcontrib>Zheng, Jin</creatorcontrib><creatorcontrib>Wang, Yi-li</creatorcontrib><creatorcontrib>Si, Lü-sheng</creatorcontrib><collection>中文科技期刊数据库</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Wanfang Data Journals - Hong Kong</collection><collection>WANFANG Data Centre</collection><collection>Wanfang Data Journals</collection><collection>万方数据期刊 - 香港版</collection><collection>China Online Journals (COJ)</collection><collection>China Online Journals (COJ)</collection><jtitle>Chinese medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Jing</au><au>Zhao, Chang-an</au><au>Wang, Kai</au><au>Zheng, Jin</au><au>Wang, Yi-li</au><au>Si, Lü-sheng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Enhanced immunization after intranasal coadministration of Escherichia coli heat-labile enterotoxin B subunit and human papillomavirus 16-L1 DNA vaccine</atitle><jtitle>Chinese medical journal</jtitle><addtitle>Chinese Medical Journal</addtitle><date>2006-03-05</date><risdate>2006</risdate><volume>119</volume><issue>5</issue><spage>408</spage><epage>411</epage><pages>408-411</pages><issn>0366-6999</issn><abstract>Human papillomavirus (HPV), mainly types 16 and 18, are the most important initiating agents of cervical cancer. Prevention of high-risk HPV infections is a potentially effective approach to control HPV associated cervical cancer.</abstract><cop>China</cop><pub>Key Laboratory of Biomedical Information Engineering of Education Ministry, Institute for Cancer Research, School of Life Science &amp; Technology, Xi'an Jiaotong University, Xi'an 710061,China</pub><pmid>16542585</pmid><doi>10.1097/00029330-200603010-00010</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0366-6999
ispartof Chinese medical journal, 2006-03, Vol.119 (5), p.408-411
issn 0366-6999
language eng
recordid cdi_wanfang_journals_zhcmj200605010
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Adjuvants, Immunologic - administration & dosage
Administration, Intranasal
Animals
Antibodies, Viral - blood
Bacterial Toxins - administration & dosage
Capsid Proteins
Enterotoxins - administration & dosage
Escherichia coli Proteins - administration & dosage
Female
Hemagglutination Inhibition Tests
Human papillomavirus 16 - immunology
Immunization
Interferon-gamma - biosynthesis
Lymphocyte Activation
Mice
Mice, Inbred C57BL
Oncogene Proteins, Viral - genetics
Oncogene Proteins, Viral - immunology
Papillomavirus Vaccines
Vaccines, DNA - administration & dosage
Vaccines, DNA - immunology
Viral Vaccines - administration & dosage
Viral Vaccines - immunology
Virion - immunology
乳头状瘤病毒
免疫机制
埃希氏菌属
疫苗
鼻内管理
title Enhanced immunization after intranasal coadministration of Escherichia coli heat-labile enterotoxin B subunit and human papillomavirus 16-L1 DNA vaccine
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T02%3A44%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wanfang_jour_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Enhanced%20immunization%20after%20intranasal%20coadministration%20of%20Escherichia%20coli%20heat-labile%20enterotoxin%20B%20subunit%20and%20human%20papillomavirus%2016-L1%20DNA%20vaccine&rft.jtitle=Chinese%20medical%20journal&rft.au=Wang,%20Jing&rft.date=2006-03-05&rft.volume=119&rft.issue=5&rft.spage=408&rft.epage=411&rft.pages=408-411&rft.issn=0366-6999&rft_id=info:doi/10.1097/00029330-200603010-00010&rft_dat=%3Cwanfang_jour_proqu%3Ezhcmj200605010%3C/wanfang_jour_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67756658&rft_id=info:pmid/16542585&rft_cqvip_id=21452945&rft_wanfj_id=zhcmj200605010&rfr_iscdi=true